1. Ketamine-associated urinary tract dysfunction: an underrecognized clinical entity.
- Author
-
Lai Y, Wu S, Ni L, Chen Z, Li X, Yang S, Gui Y, Guan Z, Cai Z, and Ye J
- Subjects
- Administration, Intravesical, Adult, Biopsy, China, Cystoscopy, Female, Humans, Hyaluronic Acid administration & dosage, Lower Urinary Tract Symptoms diagnosis, Lower Urinary Tract Symptoms drug therapy, Lower Urinary Tract Symptoms physiopathology, Male, Predictive Value of Tests, Severity of Illness Index, Treatment Outcome, Urinary Tract physiopathology, Urodynamics, Urography, Young Adult, Illicit Drugs adverse effects, Ketamine adverse effects, Lower Urinary Tract Symptoms chemically induced, Substance-Related Disorders complications, Urinary Tract drug effects
- Abstract
Introduction: The use of ketamine as a recreational drug is on the increase among young adults attending clubs and parties. Recreational ketamine users have anecdotally reported increased lower urinary tract symptoms while using the substance., Methods: We describe the severe lower urinary tract symptoms experienced in 6 patients with chronic recreational ketamine use. We obtained a detailed history and physical examination along with further investigation to identify a relationship between recreational ketamine use and these symptoms., Results: The urine cultures were sterile in all cases. Intravenous urography was performed in 3 patients and demonstrated bilateral upper ureteric narrow, mild bilateral hydronephrosis and contracted bladder urodynamic studies showed detrusor instability with urinary leakage when the bladder was filled to a capacity of 30- 50 ml. Cystoscopy revealed a small capacity bladder with erythematous lesions throughout the bladder. Bladder biopsies were performed in 3 patients and showed up as chronic cystitis. Ketamine cessation along with intravesical sodium hyaluronate solution appeared to provide some symptomatic relief., Conclusion: Ketamine-associated urinary tract dysfunction appears to be a relatively new clinical phenomenon. The pathological mechanism of ketamine-associated urinary tract dysfunction is unknown and current management strategies are ketamine cessation along with intravesical sodium hyaluronate solution., (Copyright © 2012 S. Karger AG, Basel.)
- Published
- 2012
- Full Text
- View/download PDF